Dmitry Balyasny’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-187,500
Closed -$15.9K 3163
2023
Q1
$15.9K Hold
187,500
﹤0.01% 2465
2022
Q4
$956 Hold
187,500
﹤0.01% 2702
2022
Q3
$23K Hold
187,500
﹤0.01% 2573
2022
Q2
$20K Hold
187,500
﹤0.01% 2489
2022
Q1
$60K Hold
187,500
﹤0.01% 2211
2021
Q4
$107K Buy
+187,500
New +$96.2K ﹤0.01% 1951

Dmitry Balyasny's LVACW Position: Q2 2023 in Review

Dmitry Balyasny sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q2 2023, closing a stake of 187,500 shares — an estimated $15.9K sold.

Dmitry Balyasny first reported a position in LVACW in Q4 2021 and held it in 6 quarters. The position peaked at $107K in Q4 2021. 0 funds tracked by Wall St. Rank hold LVACW as of Q2 2023.

  • Dmitry Balyasny reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
  • Dmitry Balyasny sold 187,500 LAVA Medtech Acquisition Corp. Warrants shares in Q2 2023, an estimated $15.9K.
  • Dmitry Balyasny first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q4 2021 and held it in 6 quarters.
  • Dmitry Balyasny's LAVA Medtech Acquisition Corp. Warrants position peaked at $107K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q2 2023.

Based on Balyasny Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.